Calls to Regulate E-cigarettes in New Zealand

Mar.06.2023
Calls to Regulate E-cigarettes in New Zealand
New Zealand doctors suggest making e-cigarettes prescription-only drugs following Australia's lead to address the rising youth e-cigarette use.

According to The Guardian on March 5th, several medical groups in New Zealand are calling for the country to follow Australia and classify e-cigarettes as prescription drugs. While smoking rates in New Zealand have dropped to historic lows in recent years, the proportion of underage individuals who use e-cigarettes has increased by more than three times between 2019 and 2021.


According to data released in 2022, smoking rates in New Zealand have decreased to 8%, but the daily number of people using electronic cigarettes has increased more than the decrease in daily smokers. The increase is particularly pronounced among young people, especially minors aged 14, with the proportion of daily e-cigarette users rising from 3.1% in 2019 to 9.6% in 2021.


In 2021, the Australian government introduced a law that states that vapor products containing nicotine can only be obtained through a prescription from a doctor.


Many scholars in New Zealand are advocating for the adoption of Australia's laws regulating e-cigarettes. Dr. Collin Tukuitonga, who has worked for the Ministry of Health, has said that he hopes to see the rise in youth smoking leveled off. However, if the trend continues, further restrictions may be necessary, including the possibility of making e-cigarettes available only with a prescription.


The New Zealand government is currently reviewing its e-cigarette regulations. In January of this year, Deputy Health Minister Ayesha Verrall stated that the government is consulting on amending the laws around vaping, saying that "the proportion of young people vaping is too high" and that the government "needs to strike a better balance." The proposed amendments primarily focus on limiting the sale of e-cigarettes in certain locations, reducing nicotine content, and changing packaging, rather than starting with a pharmacy or prescription model.


As previously reported by 2FIRSTS, New Zealand has become the first country in the world to implement an annual increase in the legal smoking age. On December 14, 2022, the country passed the Smoke-free Environments and Regulated Products (Smoked Tobacco) Amendment, which prohibits the sale of cigarettes to anyone born on or after January 1, 2009.


However, this legislation does not ban e-cigarette products. Previously, the New Zealand government had hoped to lower the maximum concentration of nicotine salts in disposable products from 50mg/mL to 35mg/mL, and also wanted e-cigarette companies to print serial numbers or batch numbers on their products for traceability purposes.


In January 2023, former New Zealand prime minister Jacinda Ardern revealed to the media that she believes electronic cigarettes can be an effective tool to help smokers quit.


Reference(s):


New Zealand health groups are calling for vapes to be made available only with a pharmacy prescription, according to reports.


Here is the original text of the amendment on smoke-free environments and regulated products (smoked tobacco) translated into standard journalistic English: This is the original text of the amendment that deals with smoke-free environments and regulated products, specifically smoked tobacco.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

British American Tobacco to close South Africa cigarette plant by end-2026, citing illicit trade squeezing legal market
British American Tobacco to close South Africa cigarette plant by end-2026, citing illicit trade squeezing legal market
British American Tobacco South Africa (BATSA) said it will halt local production of factory-made cigarettes and close its manufacturing plant in Heidelberg, Gauteng by the end of 2026, shifting to an import-led supply model. The company said illicit cigarettes now account for about 75% of South Africa’s market, making local manufacturing “unsustainable” and putting around 230 jobs at risk.
Jan.16
FDA PMTA Roundtable: Ongoing Comprehensive Coverage by 2Firsts
FDA PMTA Roundtable: Ongoing Comprehensive Coverage by 2Firsts
Feb.11
PMTA Manufacturing Panel Sees Small Firms Warn “Unknown Is Death” as FDA Defends Review Boundaries
PMTA Manufacturing Panel Sees Small Firms Warn “Unknown Is Death” as FDA Defends Review Boundaries
During FDA’s Feb 10 PMTA roundtable (manufacturing controls panel), small ENDS manufacturers warned that uncertainty in manufacturing expectations creates existential financial risk. FDA officials reiterated review flexibility is constrained by statutory and scientific boundaries. The panel debated testing standards, documentation requirements, open-system responsibility, supply chain changes, and software updates—highlighting unresolved PMTA challenges for small manufacturers.
Feb.11
Small ENDS Manufacturers Press FDA on Abuse Liability Standards as Agency Defines Pharmacological Review Framework
Small ENDS Manufacturers Press FDA on Abuse Liability Standards as Agency Defines Pharmacological Review Framework
At the third session of its PMTA roundtable, the FDA outlined its framework for assessing abuse liability in ENDS products, emphasizing the role of nicotine pharmacokinetics and product-specific data in APPH determinations. Small manufacturers questioned the high cost of clinical PK studies and the absence of defined numeric thresholds, while raising bridging strategies and PBPK modeling as potential alternatives.
Feb.11
NJOY and Altria ask federal court to halt ITC proceeding, alleging multiple constitutional defects
NJOY and Altria ask federal court to halt ITC proceeding, alleging multiple constitutional defects
A filing in the U.S. District Court for the Eastern District of Virginia (Richmond Division) shows NJOY and Altria entities submitted a plaintiffs’ reply supporting their motion for summary judgment, arguing the challenged ITC proceeding is unconstitutional on multiple grounds, including ALJ appointment authority, removal protections, and Article III limits under the Jarkesy framework. The plaintiffs seek summary judgment and a permanent injunction barring continuation of the ITC proceeding.
Jan.08 by 2FIRSTS.ai
Nicotine pouch brand SNÜ launches three fruit flavours, keeps “rub-and-smell” label to reduce retail shrink
Nicotine pouch brand SNÜ launches three fruit flavours, keeps “rub-and-smell” label to reduce retail shrink
UK nicotine pouch brand SNÜ has added three new flavours—Wild Cherry, Cherry Cola and Tropical Punch—spanning multiple nicotine strengths from 9mg to 60mg. The new products also retain the brand’s “rub-and-smell” packaging feature, designed to let shoppers preview the aroma without opening the can and help lower in-store product loss.
Feb.02 by 2FIRSTS.ai